Skip to main content

Year: 2021

Global Point of care Diagnostics Market Size [2021-2028] | to Reach USD 36.21 Billion by 2028

Key Players Covered in the Point of Care Diagnostics Market Research Report Are F. Hoffmann-La Roche Ltd (Basel, Switzerland), Thermo Fisher Scientific Inc. (Massachusetts, U.S.), Abbott Laboratories (Illinois, U.S), Quest Diagnostics Incorporated (New Jersey, United States), BD (Franklin Lakes, U.S), bioMérieux SA (Marcy l’Etoile, France), Cardinal Health, Inc. (Ohio, U.S), Mesa Biotech (California, U.S), Cepheid (California, U.S), Trinity Biotech (Bray, Ireland), Quidel Corporation (San Diego, U.S.), Bio-Rad Laboratories Inc. (California, U.S) and other key market players Pune, India, Dec. 07, 2021 (GLOBE NEWSWIRE) — The global Point of care Diagnostics Market size is projected to reach USD 36.21 billion by 2028, exhibiting a CAGR of -1.9% during the forecast period. The prevalence of several chronic disorders and the incorporation...

Continue reading

Semiconductor Market is to Reach USD 803.15 Billion by 2028: AP Memory Technology Corporation Joins NXP Connect Partner Program to Provide Superior Products to Customers, reports Fortune Business Insights™

Companies in Semiconductor Market are Broadcom, Inc. (California, United States), Intel Corporation (California, United States), Qualcomm (California, United States), Samsung Electronics (Suwon-si, South Korea), SK hynix (Gyeonggi, South Korea), Taiwan Semiconductors (Hsinchu, Taiwan), Texas Instruments (Texas, United States), Toshiba Corporation (Tokyo, Japan), Maxim Integrated Products, Inc. (California, United States and others Pune, India, Dec. 07, 2021 (GLOBE NEWSWIRE) — The global semiconductor market is set to gain momentum from the surging advancement in the fields of wirelessly connected devices, the Internet of Things (IoT), and artificial intelligence (AI). Micron Technology, Inc., for instance, is presently focusing on the development of multi-chip packages and high-capacity memory containing AI training for mobiles...

Continue reading

Preclinical Studies Demonstrate Sotrovimab Retains Activity Against the Full Combination of Mutations in the Spike Protein of the Omicron SARS-CoV-2 Variant

 – New preclinical findings generated through in vitro testing of sotrovimab againstthe complete pseudo-virus updated to bioRxiv – Data build on promising signal published last week, underscoring the importance of sotrovimab for early treatment of COVID-19 – – Sotrovimab is authorized and available for the treatment of early COVID-19 in the US and multiple countries around the world – LONDON and SAN FRANCISCO, Dec. 07, 2021 (GLOBE NEWSWIRE) —  GlaxoSmithKline plc (LSE/NYSE: GSK) and Vir Biotechnology, Inc. (Nasdaq: VIR) today announced an update to preclinical data on bioRxiv1, a preprint server, demonstrating that sotrovimab, an investigational monoclonal antibody, retains in vitro activity against the full known Omicron spike protein, the new SARS-CoV-2 variant (B.1.1.529). The preclinical data was generated through pseudo-virus...

Continue reading

Global Vaccines Market Size [2021-2028] | to Reach USD 104.87 Billion and Exhibit a Stellar CAGR of 10.7%

Vaccines Market Key Players Studied in this Report Are GlaxoSmithKline plc. (Brentford, United Kingdom), Sanofi (Paris, France), Pfizer Inc. (New York, United States), Merck & Co., Inc. (New Jersey, United States), Novartis AG (Basel, Switzerland), Emergent BioSolutions, Inc. (Maryland, United States), CSL Limited (Melbourne, Australia), Inovio Pharmaceuticals, Inc. (Pennsylvania, United States), Bavarian Nordic (Denmark), Mitsubishi Tanabe Pharma Corporation (Osaka, Japan), Other Prominent Players. Pune, India, Dec. 07, 2021 (GLOBE NEWSWIRE) — According to the report by Fortune Business Insights, the global Vaccines market size was USD 46.88 billion in 2019 and is projected to reach USD 104.87 billion by 2027, exhibiting a CAGR of 10.7% during the forecast period. ; Rising Demand for Cost-Effective Immunization Therapies...

Continue reading

Climate Transition Pathways (CTP) accreditation framework incubated by Willis Towers Watson continues to build cross-industry endorsement with Arch and Fidelis declaring their support

Following COP26, more insurers supporting CTP to help businesses transition to a low-carbon economy in return for continued access to insurance capacity and capital. LONDON, Dec. 07, 2021 (GLOBE NEWSWIRE) — Willis Towers Watson (NASDAQ: WLTW), a leading global advisory, broking, and solutions company, today announced their delight that Arch Insurance International have committed to align capacity, and Fidelis Insurance have endorsed Climate Transition Pathways (CTP), an accreditation framework that provides insurance companies and financial institutions with a consistent approach to identifying businesses with robust low-carbon transition plans. This follows on from the recent announcement that Liberty Specialty Markets and SCOR had become the first group of insurers to support CTP. CTP is designed to help organisations wishing...

Continue reading

Smart Meter Market Size 2019 – COVID19 Impact with Top Manufacturers Analysis | Industry Share, Revenue Forecast till 2026 : Fortune Business Insights

Companies profiled in Smart Meter Market are Siemens, ABB, Kamsturp, Itron, Landis + Gyr , Badger Meter, DiehlSecure Meter Limited, Aclara Technologies, Sensus, BMETER , Jabil, Honeywell , ZENNER Pune, India, Dec. 07, 2021 (GLOBE NEWSWIRE) — The global smart meter market size is projected to reach USD 44.18 by the end of 2026. Recent technological advancements have emerged in favor of the market in the coming years. According to a report published by Fortune Business Insights, titled “Smart Meter Market Size, Share & Industry Analysis, By Type (Smart Electric Meter, Smart Gas Meter, Smart Water Meter) By Technology (Automatic Meter Reading {AMR} and Advanced Meter Infrastructure), By Application (Residential, Commercial and Industrial), and Regional Forecast, 2019-2026,” the market was worth USD 24.53 billion in 2018 and will...

Continue reading

Advantest to Showcase Industry’s Most Advanced IC Test Solutions and Sponsor Industry Events at SEMICON Japan, December 15-17 in Tokyo

Leader in Semiconductor Testing Will Display Its Newest SoC and End-to-End Memory Test Solutions TOKYO, Dec. 07, 2021 (GLOBE NEWSWIRE) — Leading semiconductor test equipment supplier Advantest Corporation (TSE: 6857) will feature more than a dozen of its latest products and services at the SEMICON Japan trade show on December 15-17. This year’s exhibition is returning to Tokyo Big Sight as an in-person event, although some conference sessions will be offered online enabling remote participation as an option. Under the unifying theme “Converging Technologies. Advancing the Future.”, Advantest’s exhibit will put a spotlight on its contributions to accelerating the development of revolutionary test applications including AI, exascale computing, 5G communications and autonomous vehicles. Exhibition Advantest’s exhibit in booth #2347...

Continue reading

Stellantis, Foxconn Partner to Design and Sell New Flexible Semiconductors for Automotive Industry

Stellantis, Foxconn Partner to Design and Sell New Flexible Semiconductors for Automotive IndustryEnables use of cutting-edge semiconductor technology across Stellantis’ all-new STLA Brain architecture Adoption and installation of products into Stellantis vehicles targeted by 2024 Partnership will help drive stability in Stellantis’ global semiconductor supply chainAMSTERDAM, December 7, 2021 – Stellantis N.V. (NYSE / MTA / Euronext Paris: STLA) (“Stellantis”) and Hon Hai Technology Group, (“Foxconn”) (TWSE: 2317) today announced the signing of a non-binding memorandum of understanding to create a partnership with the intent to design a family of purpose-built semiconductors to support Stellantis and third-party customers. “Our software-defined transformation will be powered by great partners across industries and expertise,”...

Continue reading

AiAdvertising Adds Top Executive Talent

Chris Lynde to serve as Senior VP of Client Strategy & Execution SAN ANTONIO, Dec. 07, 2021 (GLOBE NEWSWIRE) — AiAdvertising, Inc. (AIAD), a technology driven provider of digital advertising solutions, today announced that Chris Lynde has joined the Company and will serve as Senior VP of Client Strategy & Execution. Mr. Lynde’s extensive background includes senior leadership roles at some of the nation’s largest marketing and information services organizations including MDC-Partners, Equifax Marketing Services and Experian Information Services. Most recently, Mr. Lynde was a Senior Strategist and Team Lead on Google’s Marketing Solutions team responsible for advertising strategy and optimization. At Google, he oversaw a team that consisted of 15 Strategists, 450 agencies, 1,800 advertisers and $225 million in ad spend. “Chris...

Continue reading

Mainz Biomed Launches Ecommerce Store for ColoAlert to Assist Patient Access during Covid-19 Pandemic

At-home Colorectal Cancer Diagnostic Test Now Available Online in Germany BERKELEY, Calif. and MAINZ, Germany, Dec. 07, 2021 (GLOBE NEWSWIRE) — Mainz Biomed N.V. (NASDAQ:MYNZ) (“Mainz Biomed” or the “Company”), a molecular genetics diagnostic company specializing in the early detection of cancer, is pleased to announce the launch of ColoAlert.de, an ecommerce store providing Germans direct access to its ColoAlert colorectal cancer (CRC) screening test. German residents unable to obtain timely CRC screening via in-person physician visits, will be able to order ColoAlert directly to their home and receive highly accurate results within a maximum of nine working days. “In recent years, the largest decreases in CRC mortality have been in countries with long-standing screening programs, and we are excited to bring ColoAlert, a unique,...

Continue reading

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Before you continue, please confirm the following:

Professional advisers only

I am a professional adviser and would like to visit the GOLDEA CAPITAL for Professionals website.

Important Notice for Investors:

The services and products offered by Goldalea Capital Ltd. are intended exclusively for professional market participants as defined by applicable laws and regulations. This typically includes institutional investors, qualified investors, and high-net-worth individuals who have sufficient knowledge, experience, resources, and independence to assess the risks of trading on their own.

No Investment Advice:

The information, analyses, and market data provided are for general information purposes only and do not constitute individual investment advice. They should not be construed as a basis for investment decisions and do not take into account the specific investment objectives, financial situation, or individual needs of any recipient.

High Risks:

Trading in financial instruments is associated with significant risks and may result in the complete loss of the invested capital. Goldalea Capital Ltd. accepts no liability for losses incurred as a result of the use of the information provided or the execution of transactions.

Sole Responsibility:

The decision to invest or not to invest is solely the responsibility of the investor. Investors should obtain comprehensive information about the risks involved before making any investment decision and, if necessary, seek independent advice.

No Guarantees:

Goldalea Capital Ltd. makes no warranties or representations as to the accuracy, completeness, or timeliness of the information provided. Markets are subject to constant change, and past performance is not a reliable indicator of future results.

Regional Restrictions:

The services offered by Goldalea Capital Ltd. may not be available to all persons or in all countries. It is the responsibility of the investor to ensure that they are authorized to use the services offered.

Please note: This disclaimer is for general information purposes only and does not replace individual legal or tax advice.